171 related articles for article (PubMed ID: 8554616)
1. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.
Parker JC; VanVolkenburg MA; Ketchum RJ; Brayman KL; Andrews KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):916-23. PubMed ID: 8554616
[TBL] [Abstract][Full Text] [Related]
2. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
3. The calcium/calmodulin-dependent phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion.
Han P; Werber J; Surana M; Fleischer N; Michaeli T
J Biol Chem; 1999 Aug; 274(32):22337-44. PubMed ID: 10428803
[TBL] [Abstract][Full Text] [Related]
4. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
5. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
[TBL] [Abstract][Full Text] [Related]
6. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland.
Pooley L
Biochim Biophys Acta; 2002 Jun; 1590(1-3):84-92. PubMed ID: 12063171
[TBL] [Abstract][Full Text] [Related]
7. Localization of low-KM cAMP phosphodiesterase in rat nephron segments.
Yoshida I; Takeda S; Homma S; Kusano E; Asano Y
Kidney Blood Press Res; 1997; 20(5):307-11. PubMed ID: 9419046
[TBL] [Abstract][Full Text] [Related]
8. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
9. Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin.
Härndahl L; Jing XJ; Ivarsson R; Degerman E; Ahrén B; Manganiello VC; Renström E; Holst LS
J Biol Chem; 2002 Oct; 277(40):37446-55. PubMed ID: 12169692
[TBL] [Abstract][Full Text] [Related]
10. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
11. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP
J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
Whalin ME; Garrett RL; Thompson WJ; Strada SJ
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes.
Hermsdorf T; Dettmer D
Cell Signal; 1998 Oct; 10(9):629-35. PubMed ID: 9794244
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production.
Beshay E; Prud'homme GJ
Lab Invest; 2001 Aug; 81(8):1109-17. PubMed ID: 11502862
[TBL] [Abstract][Full Text] [Related]
15. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
Dousa TP
Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of phosphodiesterase PDE-3/PDE-4-specific inhibitors on vasoconstriction and cAMP-dependent vasorelaxation following balloon angioplasty.
Zhao H; Quilley J; Montrose DC; Rajagopalan S; Guan Q; Smith CJ
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2973-81. PubMed ID: 17293498
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
Matousovic K; Grande JP; Chini CC; Chini EN; Dousa TP
J Clin Invest; 1995 Jul; 96(1):401-10. PubMed ID: 7615811
[TBL] [Abstract][Full Text] [Related]
19. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
20. Type IV phosphodiesterase inhibitor suppresses insulin-dependent myocardial glucose uptake.
Imahashi K; Yoshioka J; Yamakita T; Yamano S; Kusuoka H; Nishimura T
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):290-1. PubMed ID: 11251642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
